FC
RMD icon

Financial Consulate’s ResMed RMD Stock Holding History

Financial Consulate’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14K Hold
11
– – ﹤0.01% 1011
2026
Q1 		$2.47K Buy
11
+1
+10% +$249 ﹤0.01% 942
2025
Q4 		$2.41K Hold
10
– – ﹤0.01% 853
2025
Q3 		$2.74K Buy
+10
New +$2.73K ﹤0.01% 745

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Financial Consulate's RMD Position: Q2 2026 in Review

Financial Consulate held its ResMed (RMD) position steady in Q2 2026 at 11 shares worth $2.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Financial Consulate first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.74K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Financial Consulate held 11 shares of ResMed worth $2.14K as of Q2 2026.
  • Financial Consulate left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #1011 holding.
  • Financial Consulate first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • Financial Consulate's ResMed position peaked at $2.74K in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.